Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX013
Go back to Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX013| Janex International, Inc. (NASDAQ: JANX) | Delayed: 17.47 +0.46 (2.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.01 | 52 Week High | $0.01 | |||
| Open | $17.17 | 52 Week Low | $0.00 | |||
| Day High | $17.47 | P/E | N/A | |||
| Day Low | $16.97 | EPS | $0.00 | |||
| Volume | 908,285 | |||||
